vs

Side-by-side financial comparison of La Rosa Holdings Corp. (LRHC) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $13.2M, roughly 1.5× TriSalus Life Sciences, Inc.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -73.9%, a 46.5% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 3.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs 43.0%).

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

LRHC vs TLSI — Head-to-Head

Bigger by revenue
LRHC
LRHC
1.5× larger
LRHC
$20.2M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+56.7% gap
TLSI
59.8%
3.2%
LRHC
Higher net margin
LRHC
LRHC
46.5% more per $
LRHC
-27.4%
-73.9%
TLSI
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
43.0%
TLSI

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
LRHC
LRHC
TLSI
TLSI
Revenue
$20.2M
$13.2M
Net Profit
$-5.5M
$-9.8M
Gross Margin
8.4%
86.7%
Operating Margin
-24.7%
-24.8%
Net Margin
-27.4%
-73.9%
Revenue YoY
3.2%
59.8%
Net Profit YoY
-125.7%
3.5%
EPS (diluted)
$-5.44
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LRHC
LRHC
TLSI
TLSI
Q4 25
$13.2M
Q3 25
$20.2M
$11.6M
Q2 25
$23.2M
$11.2M
Q1 25
$17.5M
$9.2M
Q4 24
$17.7M
$8.3M
Q3 24
$19.6M
$7.3M
Q2 24
$19.1M
$7.4M
Q1 24
$13.1M
$6.5M
Net Profit
LRHC
LRHC
TLSI
TLSI
Q4 25
$-9.8M
Q3 25
$-5.5M
$-10.8M
Q2 25
$78.4M
$-8.3M
Q1 25
$-95.7M
$-10.4M
Q4 24
$-5.1M
$-10.1M
Q3 24
$-2.5M
$-2.4M
Q2 24
$-2.3M
$-4.3M
Q1 24
$-4.6M
$-13.2M
Gross Margin
LRHC
LRHC
TLSI
TLSI
Q4 25
86.7%
Q3 25
8.4%
83.5%
Q2 25
8.0%
83.9%
Q1 25
8.8%
83.7%
Q4 24
8.9%
85.3%
Q3 24
8.3%
86.3%
Q2 24
8.3%
87.6%
Q1 24
8.9%
85.0%
Operating Margin
LRHC
LRHC
TLSI
TLSI
Q4 25
-24.8%
Q3 25
-24.7%
-77.9%
Q2 25
-10.6%
-65.4%
Q1 25
-26.7%
-79.9%
Q4 24
-17.1%
-91.8%
Q3 24
-8.9%
-118.9%
Q2 24
-9.7%
-111.0%
Q1 24
-35.0%
-180.8%
Net Margin
LRHC
LRHC
TLSI
TLSI
Q4 25
-73.9%
Q3 25
-27.4%
-93.5%
Q2 25
337.8%
-73.9%
Q1 25
-546.5%
-113.2%
Q4 24
-28.7%
-122.4%
Q3 24
-12.5%
-32.6%
Q2 24
-12.2%
-58.8%
Q1 24
-35.1%
-204.5%
EPS (diluted)
LRHC
LRHC
TLSI
TLSI
Q4 25
$-0.22
Q3 25
$-5.44
$-0.96
Q2 25
$15.25
$-0.27
Q1 25
$-5.86
$-0.39
Q4 24
$28.54
$-0.38
Q3 24
$-16.49
$-0.12
Q2 24
$-12.49
$-0.21
Q1 24
$-0.35
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LRHC
LRHC
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$4.0M
$20.4M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$1.6M
$-33.9M
Total Assets
$21.7M
$35.3M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LRHC
LRHC
TLSI
TLSI
Q4 25
$20.4M
Q3 25
$4.0M
$22.7M
Q2 25
$5.1M
$26.5M
Q1 25
$2.9M
$13.0M
Q4 24
$1.4M
$8.5M
Q3 24
$1.8M
$11.3M
Q2 24
$1.6M
$16.5M
Q1 24
$1.1M
$4.0M
Total Debt
LRHC
LRHC
TLSI
TLSI
Q4 25
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
LRHC
LRHC
TLSI
TLSI
Q4 25
$-33.9M
Q3 25
$1.6M
$-26.7M
Q2 25
$3.4M
$-19.4M
Q1 25
$-87.5M
$-34.4M
Q4 24
$2.6M
$-25.9M
Q3 24
$5.0M
$-20.4M
Q2 24
$4.7M
$-25.3M
Q1 24
$5.6M
$-36.0M
Total Assets
LRHC
LRHC
TLSI
TLSI
Q4 25
$35.3M
Q3 25
$21.7M
$36.5M
Q2 25
$22.9M
$41.3M
Q1 25
$21.0M
$28.6M
Q4 24
$19.4M
$24.0M
Q3 24
$19.7M
$27.5M
Q2 24
$18.7M
$32.4M
Q1 24
$16.3M
$17.9M
Debt / Equity
LRHC
LRHC
TLSI
TLSI
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LRHC
LRHC
TLSI
TLSI
Operating Cash FlowLast quarter
$-1.3M
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LRHC
LRHC
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-1.3M
$-3.7M
Q2 25
$-1.4M
$-7.3M
Q1 25
$-3.5M
$-4.5M
Q4 24
$-1.1M
$-5.7M
Q3 24
$-591.6K
$-10.8M
Q2 24
$-803.1K
$-13.4M
Q1 24
$-538.3K
$-10.9M
Free Cash Flow
LRHC
LRHC
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
LRHC
LRHC
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
LRHC
LRHC
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%
Cash Conversion
LRHC
LRHC
TLSI
TLSI
Q4 25
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

TLSI
TLSI

Segment breakdown not available.

Related Comparisons